{
    "patient": {
        "Name": "Daniel Flores",
        "DateOfBirth": "1978-12-04",
        "Sex": "Male",
        "Diagnosis": "Pancreatic neuroendocrine tumors",
        "BodyPart": "Pancreatic",
        "Physician": "Dr. Philip Marquez",
        "TreatingInstitution": "Bishop-Thompson"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Pancreatic",
            "CollectedDate": "2023-05-09",
            "ReceivedDate": "2023-05-09",
            "TumorPercentage": "5%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-05-11",
            "ReceivedDate": "2023-05-11"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "ARID2",
                "DNA Alteration": " c.798G>A",
                "GeneMutation": "p.W266* Stopgain-LOF",
                "VariantAlleleFraction": "35.9%"
            },
            {
                "Gene": "IDH1",
                "DNA Alteration": "c.394_395delinsTC",
                "GeneMutation": "p.R132H Nonsense-GOF",
                "VariantAlleleFraction": "32.59%"
            },
            {
                "Gene": "TOP2A",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.A1515S Stopgain-LOF",
                "VariantAlleleFraction": "25.8%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "FGFR3",
                "DNA Alteration": "c.1111A>T",
                "GeneMutation": "p.A1515S Spliceregionvariant-LOF",
                "VariantAlleleFraction": "15.97%"
            },
            {
                "Gene": "IDH1",
                "DNA Alteration": "c.394_395delinsTC",
                "GeneMutation": "p.R132C Nonsense-LOF",
                "VariantAlleleFraction": "2.0%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "PKLR",
            "BRCA1"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "48 m/Mb",
            "Tmbpercentile": "17%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Equivocal"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}